Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.


International Journal for Basic and Clinical Studies on Neuroendocrine Relationships

Guidelines for Authors

Manuscript Submission
Plagiarism Policy
Digital Object Identifier (DOI)
Supplementary Material
Self-Archiving/Green Open Access, Author's ChoiceTM,
   Funding Organizations (NIH etc.)

E-pub First


The Editorial Board of ‘Neuroendocrinology’ welcomes articles for review that report new observations on interactions between the brain and the endocrine system.

Papers that are published deal with both basic and clinical subjects. Editorials, summaries of meetings, and reviews of timely topics in basic and clinical neuroendocrinology are also published, but these items are accepted only at the invitation of the Editor-in-Chief.

Manuscript Submissions

Manuscripts written in English should be submitted online:

Online Manuscript Submission

Should you have any problems with your submission, please contact the Editorial Office at

Editorial Office 'Neuroendocrinology'
Prof. Dr. Robert Millar
South Lodge
295 Gilmerton Road
Edinburgh EH16 5UL (UK)

Editorial Manager
Dr. Allison Kirsop
E-Mail editor@nen-edinburgh.org

Manuscripts should contain unpublished results of research work, and should be as concise as possible.

The following presentation is recommended:
Abstract, Introductory statement on the purpose of the studies, Materials and Methods, Results, Discussion, and References.

Current abbreviations should be used throughout the text and tables:
– for pituitary hormones ACTH, beta-END, FSH, GH, LH, TSH
– for neuropeptides CRH, not CRF; GAL; GHRH, not GRF; GnRH, not LHRH; NPY;
   NT; SRIH, not SRIF; VIP etc.
and a definition should be provided the first time each abbreviation appears. Please limit abbreviations to those in common use, and avoid other abbreviations and acronyms.

Manuscripts should contain novel, original data. As a rule, the Editorial office commits itself to achieve initial review of manuscripts within less than 60 days; average interval between submission and publication is 7–9 months.

Authors of articles reporting mostly confirmatory, fragmentary or preliminary findings may be notified within 2 weeks that their manuscript will not be submitted to formal review. Such a proposal will be made by the associate Editors assisted by one member of the Editorial Board. This procedure is intended to provide rapid feedback to authors of manuscripts which have a poor chance of being accepted. Authors have the opportunity to appeal against the decision.

Contributors should know that one of the criteria considered in reviewing manuscripts is the humane and proper treatment of animals. The editors realize that the use of anesthetics, analgesics, and tranquilizers would defeat the purpose of some experiments. However, the use of painful or otherwise noxious stimuli must be carefully and thoroughly justified in the paper.

Papers that do not meet these criteria will not be accepted for publication.


All manuscripts are subject to editorial review. Manuscripts are received with the explicit understanding that they are not under simultaneous consideration by any other publication. Submission of an article for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of Neuroendocrinology and may not be reproduced by any means, in whole or in part, without the written consent of the publisher. It is the author’s responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.
For legal reasons, we must receive your 'Submission Statement' with your original (hand-written) signature. Please download, print, sign and either fax or scan it to make it legally binding.

Plagiarism Policy

Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation.
If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).


Title page: The first page of each paper should carry the title, the authors’ full first and last names, and the name of the institute or department where the authors conducted their research work.

In addition, the following should be put on the title page:
   1. A short title for use as a running head.
   2. A list of 3–9 key words.
   3. The name and complete mailing address as well as phone and fax numbers of the individual to whom correspondence, proofs, and requests for reprints should be addressed.
NB: Authors wishing to preserve the phonetic meaning of diacritics (PubMed reduces diacritics to their root characters) must spell their names accordingly when submitting manuscripts (e.g. Müller should be Mueller).

Abstract: Each paper must have a short abstract describing procedures, observations and conclusions, which will appear at the beginning of the article. Abstracts should not exceed 250 words.

Footnotes: Avoid footnotes if at all possible. When essential, they should be numbered consecutively and typed at the foot of the appropriate page.

Acknowledgements: Including, where relevant, credit to the sources of grant support.

Tables and illustrations: Tables (numbered in Arabic numerals) should be prepared on separate sheets, and each should have a suitable heading. Illustrations should be numbered in Arabic numerals and legends for the figures should be submitted on a separate page. For the reproduction of illustrations, only good drawings and original photographs can be accepted; negatives or photocopies cannot be used. Due to technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations on one block for reproduction (max. size 180 x 223 mm) or provide crop marks. Electronically submitted b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800-1200 dpi.


In the text identify references by Arabic numerals [in square brackets]. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of all the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org).


(a) Papers published in periodicals: Sun J, Koto H, Chung KF: Interaction of ozone and allergen challenges on bronchial responsiveness and inflammation in sensitised guinea pigs. Int Arch Allergy Immunol 1997;112:191–195.

(b) Papers published only with DOI numbers: Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.

(c) Monographs: Matthews DE, Farewell VT: Using and Understanding Medical Statistics, ed 3, revised. Basel, Karger, 1996.

(d) Edited books: Parren PWHI, Burton DR: Antibodies against HIV-1 from phage display libraries: Mapping of an immune response and progress towards antiviral immunotherapy; in Capra JD (ed): Antibody Engineering. Chem Immunol. Basel, Karger, 1997, vol 65, pp 18–56. Papers that have been submitted to a journal but are not yet accepted should not be listed in the bibliography, but the data in them can be referred to in the text as unpublished observations. If details of methods are only available in papers that are ‘in press’, copies of the papers should be included with the manuscript submitted to Neuroendocrinology, so that the editorial referees can have adequate information to judge the manuscript.

Reference Management Software: Use of EndNote is recommended for easy management and formatting of citations and reference lists.

Digital Object Identifier (DOI)

S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org

Supplementary Material

Multimedia files and other supplementary files, directly relevant but not essential to the conclusions of a paper, enhance the online version of a publication and increase its visibility on the web. These files will undergo editorial review. The Editors reserve the right to limit the scope and length of the supplementary material. Multimedia and supplementary material should meet production quality standards for publication without the need for any modification or editing. Files should not exceed 10 MB in size. Figures and tables need to have titles and legends, and all files should be supplied separately and labeled clearly. All supplementary material should be referred to in the main text. A DOI number will be assigned to supplementary material and it will be hosted online at https://karger.figshare.com under a CC BY license. Authors will be charged a processing fee of CHF 250.00 for supplementary material.

Self-Archiving/Green Open Access

Karger permits authors to archive their pre-prints (i.e. pre-peer review) or post-prints (i.e. accepted manuscript after peer review but before production) on their personal or their institution’s internal website. In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks (e.g. ResearchGate or Mendeley) no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must:

  • Be used for noncommercial purposes only
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘This is the peer-reviewed but unedited manuscript version of the following article: [insert full citation, e.g. Cytogenet Genome Res 2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Manuscripts to be archived in PubMed Central due to funding requirements will be submitted by Karger on the author’s behalf [see Funding Organizations (NIH etc.)].

For self-archiving Author's ChoiceTM (Gold Open Access) articles, see Author's ChoiceTM.

Author's ChoiceTM

Karger’s Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.karger.com. The option is available for a one-time fee of CHF 3,000.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
The final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license. Reposted Open Access articles must:

  • Follow the terms of the relevant Creative Commons license
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘The final, published version of this article is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Funding Organizations (NIH etc.)

The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits NIH-funded articles to PMC on behalf of the authors immediately upon publication. The NIH assigns a PMCID within approximately 1 month and the manuscript will appear in PMC after a 12-month embargo. For authors making their paper Open Access through Author's ChoiceTM, the embargo will be overridden, thereby accelerating the accessibility of the article. Karger also complies with other funders’ requirements (including Wellcome Trust and RCUK) for submission to PMC.
Authors should include information on their grant in the Acknowledgements section of their papers.


Unless indicated otherwise, a PDF for correction is sent to the corresponding author and should be returned with the least possible delay. Alterations other than the correction of printer's errors are charged to the author.

E-pub First

All articles are published electronically ahead of print with a DOI number and are supplemented later with the definite reference of the printed version. The articles become available immediately after the authors' approval to publication, with the added advantage of being citable much earlier than in print. Authors can influence the time of appearance by promptly returning the proofs.


Order forms and a price list are sent with the PDF. Orders submitted after the issue is printed are subject to considerably higher prices.